Clique no nome do convidado e confira o minicurrículo:

Convidados Internacionais

Professor of Neurology, The National Hospital for Neurology and Neurosurgery, Queen Square and Emeritus Director, Reta Lila Weston Institute of Neurological Studies, University College London, Institute of Neurology
Born on Merseyside, Andrew Lees qualified in medicine at the Royal London Hospital Medical College in 1970. His neurological training was at University College London Hospitals and the National Hospital for Neurology and Neurosurgery, Queen Square. He also spent time at L’Hopital Salpetriere, Paris.
At the age of thirty-two he was appointed to the consultant staff at the National Hospitals, The Middlesex, and Whittington Hospitals and in 1987 was elected a Fellow of the Royal College of Physicians. He was later appointed Professor of Neurology at the National Hospital for Neurology and Neurosurgery, Queen Square and was Director of the Reta Lila Weston Institute for Neurological Studies (1998-2012). He was Clinical Director of the Queen Square Brain Bank for Neurological Disorders (1985-2012) and Director of the Sara Koe PSP Research Centre (2002-2012).
He is a Visiting Professor at the University of Liverpool and has close collaborations with a number of Brazilian universities. For his contributions to Brazilian neurology he was elected an overseas member of the Academia Nacional de Medicina and the Academia Brasileira de Neurologica. He was elected as a Council member of the Academy of Medical Sciences 2012- 2015. Appointed as an Expert Adviser for the UK Government National Institute for Health and Care Excellence Centre for Guidelines (2006-2019).

Andrew has achieved international recognition for his work on Parkinson’s disease and abnormal movement disorders. He is an original member of the Highly Cited Researchers ISI Database with an h-index of 120. Founder member of the international Movement Disorder Society, he was elected President (2004-2006) and co-edited the Movement Disorders Journal between 1995 and 2003. In 2006, he was awarded the Movement Disorders Research Award by the American Academy of Neurology. In recent years he has delivered the Gowers Memorial Lecture at the National Hospital, The Inaugural Lord Brain Memorial Lecture at Barts and the Royal London Hospitals and David Marsden Memorial Lecture at the European Federation of Neurological Societies. He was the recipient of Stanley Fahn Lectureship Award, MDS Dublin 2012, and has been awarded the German Society of Neurology’s 2012 Dingebauer Prize for outstanding scientific attainment in the field of Parkinson‘s disease and Neurodegenerative Disorders.
In 2014, Andrew received the prestigious Jay Van Andel award for outstanding research in Parkinson’s disease. Based in Grand Rapids Michigan, the Van Andel Institute is an independent research organisation dedicated to preserving, enhancing and expanding the frontiers of medical science. In 2015, he became the recipient of the Association of British Neurologists Medal, awarded annually in recognition of outstanding contributions by British and Irish neurologists to the science and practice of neurology. He received the Bing Spear Award in 2016 for outstanding contributions towards saner drug policies, and has been awarded the Parkinson Canada’s Donald Calne Award and Lectureship for 2017.

Professor, Department of Neurology, Johns Hopkins School of Medicine
Associate Director, Sleep Disorders Center, JHBMC
Recipient of the AAN Sleep Science Award which is given in “recognition of outstanding achievements in Sleep Science Research”
Elected, Fellow of the Royal College of Physician, Ireland (FRCP(I)) in recognition of my work in Restless Legs Syndrome.

Dr. Francesc Graus is the chief of service of Neurology of the Hospital Clinic in Barcelons, Spain. The area of research of Dr. Graus has been the clinical and immunological characterization of the paraneoplastic neurological syndromes. He led the panel of experts that defined for the first time strict criteria for their diagnosis. His research has been important for the confirmation of the immune hypothesis that the underlying tumor triggers and autoimmune attack to the nervous system causing the neurological dysfunction. In the last years he has been involved in the field of autoimmune encephalitis and other CNS disorders associated with antibodies against neuronal surface antigens. The research in this area led to the characterization of the anti-IgLON5 disease, an intriguing CNS disorder at the crossroad of autoimmunity and neurodegeneration.

My main interest is neurology and genetics. My early-career focused on major disease gene discovery with linkage analysis in Alzheimer’s disease (AD), leading to chromosome 21 and subsequently APP mutations as the first genetic cause of AD (Nature;353,344-46); the Swedish APP double mutation in AD (Nature Genetics;1,345-47) and the Tau gene (Nature;393,702-705). At UCL I have worked on common and rare disorders in neurogenetics, with significant impact resulting in the identification of genes for ataxia (Nature Genetics;39,1434-6 and Cell Rep;28;16:79-91), neuromuscular diseases (AJHG;93,976–983 and 95,590–601), spastic paraplegia (Annals Neurology;74,850-4 and Brain;139:1904-18), parkinsonian disorders and dystonia (Annals Neurology;73,546-553, Nature Genetics;46,989-93 and Brain;138:3567-80). I lead the recently established Neurology and Neurodegeneration Genomics England Clinical Interpretation Partnership (GeCIP), setup to examine all neurology genomes from the 100,000 genomes project ( and represents all rare diseases on the Genomics England board. In addition, his research and accredited diagnostic laboratory has established an open-access fibroblast/lymphoblast bank and the worldwide Synaptopathies Genetic Consortium ( working on rare disease genomics. As a group we are very keen to collaborate on neurogenetic conditions

Norman Latov, M.D., Ph.D. is Professor of Neurology and Neuroscience, and Director of the Peripheral Neuropathy Clinical and Research Center at the Weill Medical College of Cornell University. He graduated from Columbia College, received the MD,PhD degree from the University of Pennsylvania, and completed the residency in Neurology at the Neurological Institute of Columbia University. After a fellowship in Immunology, he joined the faculty at Columbia University where he was appointed as Professor of Neurology. He has been at the Weill Cornell Medical College since 2001. Dr. Latov’s clinical and research interests focus on the diagnosis and treatment of inflammatory neuropathies. His laboratory is credited with the discovery of anti-MAG and anti-GM1 ganglioside antibodies, and the development of diagnostic tests for these condition in patients with neuropathy. He also served on the steering committees of several international clinical peripheral neuropathy trials, including the ICE trial that led to FDA approval of intravenous immunoglobulin (IVIG) for the treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). He lectures widely, and published over 200 research articles, reviews, editorials, chapters and books.

Dr. Nogueira completed his Neurology Residency at the Massachusetts General Hospital (MGH) and Brigham and Women’s Hospital/ Harvard Medical School. He then completed Fellowships in Vascular and Critical Care Neurology as well as Neurointerventional Surgery at the MGH where he remained as a faculty member for five additional years. He moved to Atlanta in 2010 to help building the Marcus Stroke & Neuroscience Center at the Grady Memorial Hospital where he serves as the Director of the Neuroendovascular Service. He is a Professor of Neurology, Neurosurgery and Radiology at the Emory University School of Medicine, the Editor-in-Chief for the Interventional Neurology Journal and the Immediate Past President of the Society of Vascular and Interventional Neurology (SVIN). He has been involved in most of the mechanical thrombectomy trials. He was the Principal Investigator of the DAWN, Penumbra 3D Separator, and TREVO-2 trials and a Steering Committee member for the SWIFT, SWIFT Prime, and ARISE-II trials. He is currently the Principal Investigator for the RESILIENT and ENDOLOW trials. He has published over 250 manuscripts in peer-reviewed medical journals.

Chairman of the Paediatric Subcommittee of the International Headache Society ( 1995-2003). Member of the Executive Committee of the International Headache Society (2003-2009). Founder of the International Headache Society Master School. Past- President of the Italian Headache Society ( 2009-2010). Chairman of the Executive of Child and Adolescent Neuropsychiatry University Professors. Member of the Executive of Italian Medical Professor Association. Director of Postgraduate School in Child and Adolescent Neuropsychiatry. Speaker in 364 congresses (121 international congresses, 144 oral presentations). Magisterial Lectures in USA,Cuba, Chile, Uruguay, Brasil, China, Chorea, Japon, Turkey, Georgia, Israel, Hungary, Norway, Holland, Spain, Germany, Albania, Swiss, Austria, Bulgaria, Italy.

Professor Werner Poewe is Professor of Neurology and Director of the Department of Neurology at Medical University Innsbruck, Austria since 1995. Professor Poewe’s main research interests in the field of movement disorders are focussed on differential and early diagnosis of Parkinson’s disease, its natural history and pharmacological treatment. He has been involved in the steering committees of numerous drug trials in different stages of Parkinson’s disease for the past 20 years and has authored and co-authored more than 650 original articles and reviews in the field of movement disorders. Professor Poewe served as President of the International Movement Disorder Society from 2000-2002. Professor Poewe took over as chair of the MDS European Section from 2011-2013 and is currently active as member of the Managing Board of the Movement Disorder Scientific Panel of the European Academy of Neurology.

Fique atento ÀS
datas principais


Segundo vencimento
para inscrições com desconto!


Restam 2 dias
para que você
envie seu resumo!

Trabalhos Científicos

Veja as regras para envio dos resumos e fique atento aos prazos.

Programação Científica

Consulte a programação completa das palestras e cursos disponíveis.

Turismo e Hospedagem

Não se preocupe, deixe que cuidaremos disso pra você!


São Paulo

A cidade que não para!
Mais que uma cidade, uma metrópole, São Paulo é uma das maiores forças do Brasil. Fundada em 1554 pelos jesuítas, São Paulo, capital do maior Estado do sudeste Brasileiro, é também o principal centro financeiro e de negócios da América Latina. Cidade mais populosa do Brasil, do continente americano e de todo o hemisfério sul do mundo, São Paulo é também considerada a cidade brasileira mais influente no cenário global.

Local do Evento

Transamerica Expo Center

O Transamerica Expo Center é um centro de convenções e exposições, localizado em Santo Amaro, zona sul de São Paulo, que fica no entorno de centros de compras e entretenimento, como o shopping Morumbi, Market Place, Cidade Jardim, Teatro Alfa e o Autódromo de Interlagos. É dotado de uma área de 100.000 m², sendo 40.000 m² de área locável e 2.500 vagas de estacionamento.

Avenida Dr. Mario Villas Boas Rodrigues, 387,
Santo Amaro - São Paulo - SP

Entidades realizadoras


4007 2249
55 51 3086 9100

Agência de Turismo

Patrocinador Diamante

Patrocinador Ouro

Patrocinador Prata

Patrocinador Bronze